Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

NCT06952452 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

630

Enrollment

OTHER

Sponsor class

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG: Bevacizumab
DRUG: Ranibizumab Ophthalmic

Sponsor

Parc de Salut Mar

Collaborators

[object Object]